Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Journal of Oncology Practice
|
March 13, 2019
Moving Toward Targeted Therapy in the Treatment of Angioimmunoblastic T-Cell Lymphoma
Pamela B Allen
Blood
|
August 31, 2023
DMF in CTCL: where do we go from here?
Pamela B Allen
Current Oncology Reports
|
April 17, 2020
Therapy of Peripheral T Cell Lymphoma: Focus on Nodal Subtypes
Pamela B Allen, Barbara Pro
Current Hematologic Malignancy Reports
|
January 12, 2025
Advances in Novel Systemic Therapies for the Management of Cutaneous T Cell Lymphoma (CTCL)
Katherine B Case, Pamela B Allen
Expert Review of Pharmacoeconomics & Outcomes Research
|
March 1, 2018
Balancing patient value and payer cost in hematologic malignancies: can it be done?
Pamela B Allen, Christopher R Flowers
Cancer Management and Research
|
December 26, 2018
Hematologic toxicity is rare in relapsed patients treated with belinostat: a systematic review of belinostat toxicity and safety in peripheral T-cell lymphomas
Pamela B Allen, Mary Jo Lechowicz
Journal of Oncology Practice
|
October 11, 2019
Management of NK/T-Cell Lymphoma, Nasal Type
Pamela B Allen, Mary Jo Lechowicz
Current Oncology Reports
|
March 29, 2019
Controversies in the Approach to Initial Therapy of Hodgkin Lymphoma
Pamela B Allen, Jane N Winter
Clinical Medicine Insights. Oncology
|
October 10, 2017
Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors
Pamela B Allen, Leo I Gordon
Oncology (Williston Park, N.Y.)
|
November 18, 2020
Supporting Decision-Making on Fertility Preservation Among Adolescent and Young Adult Women With Cancer
Jackelyn B Payne, Christopher R Flowers, Pamela B Allen
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Journal of Oncology Practice
|
March 13, 2019
Moving Toward Targeted Therapy in the Treatment of Angioimmunoblastic T-Cell Lymphoma
Pamela B Allen
Blood
|
August 31, 2023
DMF in CTCL: where do we go from here?
Pamela B Allen
Current Oncology Reports
|
April 17, 2020
Therapy of Peripheral T Cell Lymphoma: Focus on Nodal Subtypes
Pamela B Allen, Barbara Pro
Current Hematologic Malignancy Reports
|
January 12, 2025
Advances in Novel Systemic Therapies for the Management of Cutaneous T Cell Lymphoma (CTCL)
Katherine B Case, Pamela B Allen
Expert Review of Pharmacoeconomics & Outcomes Research
|
March 1, 2018
Balancing patient value and payer cost in hematologic malignancies: can it be done?
Pamela B Allen, Christopher R Flowers
Cancer Management and Research
|
December 26, 2018
Hematologic toxicity is rare in relapsed patients treated with belinostat: a systematic review of belinostat toxicity and safety in peripheral T-cell lymphomas
Pamela B Allen, Mary Jo Lechowicz
Journal of Oncology Practice
|
October 11, 2019
Management of NK/T-Cell Lymphoma, Nasal Type
Pamela B Allen, Mary Jo Lechowicz
Current Oncology Reports
|
March 29, 2019
Controversies in the Approach to Initial Therapy of Hodgkin Lymphoma
Pamela B Allen, Jane N Winter
Clinical Medicine Insights. Oncology
|
October 10, 2017
Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors
Pamela B Allen, Leo I Gordon
Oncology (Williston Park, N.Y.)
|
November 18, 2020
Supporting Decision-Making on Fertility Preservation Among Adolescent and Young Adult Women With Cancer
Jackelyn B Payne, Christopher R Flowers, Pamela B Allen
Page
of 4